With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Seventh Edition of the world's best-selling formulary in psychopharmacology. The new edition features nine new compounds as well as information about several new formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The Pearls have all been refreshed and the antipsychotics section has been completely revised. With its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.
Muu info
This fully updated Seventh Edition, includes nine new drugs, and remains the indispensable guide for all mental health prescribers.
|
Introduction |
|
xi |
|
|
|
|
xv |
|
|
|
|
1 |
(4) |
|
|
|
5 |
(6) |
|
|
|
11 |
(6) |
|
|
|
17 |
(8) |
|
|
|
25 |
(8) |
|
|
|
33 |
(6) |
|
|
|
39 |
(6) |
|
|
|
45 |
(8) |
|
|
|
53 |
(12) |
|
|
|
65 |
(6) |
|
|
|
71 |
(8) |
|
|
|
79 |
(6) |
|
|
|
85 |
(4) |
|
|
|
89 |
(6) |
|
|
|
95 |
(4) |
|
|
|
99 |
(4) |
|
|
|
103 |
(8) |
|
|
|
111 |
(6) |
|
|
|
117 |
(6) |
|
|
|
123 |
(4) |
|
|
|
127 |
(4) |
|
|
|
131 |
(6) |
|
|
|
137 |
(10) |
|
|
|
147 |
(6) |
|
|
|
153 |
(6) |
|
|
|
159 |
(6) |
|
|
|
165 |
(8) |
|
|
|
173 |
(6) |
|
|
|
179 |
(6) |
|
|
|
185 |
(6) |
|
|
|
191 |
(10) |
|
|
|
201 |
(6) |
|
|
|
207 |
(8) |
|
|
|
215 |
(6) |
|
|
|
221 |
(4) |
|
|
|
225 |
(4) |
|
|
|
229 |
(6) |
|
|
|
235 |
(4) |
|
|
|
239 |
(4) |
|
|
|
243 |
(6) |
|
|
|
249 |
(6) |
|
|
|
255 |
(8) |
|
|
|
263 |
(6) |
|
|
|
269 |
(6) |
|
|
|
275 |
(6) |
|
|
|
281 |
(4) |
|
|
|
285 |
(4) |
|
|
|
289 |
(4) |
|
|
|
293 |
(4) |
|
|
|
297 |
(4) |
|
|
|
301 |
(6) |
|
|
|
307 |
(6) |
|
|
|
313 |
(8) |
|
|
|
321 |
(4) |
|
|
|
325 |
(6) |
|
|
|
331 |
(6) |
|
|
|
337 |
(6) |
|
|
|
343 |
(4) |
|
|
|
347 |
(8) |
|
|
|
355 |
(4) |
|
|
|
359 |
(8) |
|
|
|
367 |
(8) |
|
|
|
375 |
(8) |
|
|
|
383 |
(4) |
|
|
|
387 |
(8) |
|
|
|
395 |
(4) |
|
|
|
399 |
(4) |
|
|
|
403 |
(6) |
|
|
|
409 |
(6) |
|
|
|
415 |
(6) |
|
|
|
421 |
(6) |
|
|
|
427 |
(4) |
|
|
|
431 |
(6) |
|
|
|
437 |
(6) |
|
|
|
443 |
(8) |
|
|
|
451 |
(6) |
|
|
|
457 |
(8) |
|
|
|
465 |
(8) |
|
|
|
473 |
(4) |
|
|
|
477 |
(4) |
|
|
|
481 |
(6) |
|
|
82 Methylphenidate (D, L) |
|
|
487 |
(8) |
|
|
|
495 |
(4) |
|
|
|
499 |
(4) |
|
|
|
503 |
(6) |
|
|
|
509 |
(6) |
|
|
|
515 |
(6) |
|
|
|
521 |
(6) |
|
|
|
527 |
(6) |
|
|
|
533 |
(4) |
|
|
|
537 |
(4) |
|
|
|
541 |
(4) |
|
|
|
545 |
(6) |
|
|
|
551 |
(8) |
|
|
|
559 |
(10) |
|
|
|
569 |
(6) |
|
|
|
575 |
(6) |
|
|
|
581 |
(12) |
|
|
|
593 |
(8) |
|
|
|
601 |
(6) |
|
|
|
607 |
(6) |
|
|
|
613 |
(6) |
|
|
103 Phentermine/Topiramate |
|
|
619 |
(4) |
|
|
|
623 |
(4) |
|
|
|
627 |
(6) |
|
|
|
633 |
(6) |
|
|
|
639 |
(4) |
|
|
|
643 |
(4) |
|
|
|
647 |
(6) |
|
|
|
653 |
(4) |
|
|
|
657 |
(6) |
|
|
|
663 |
(4) |
|
|
|
667 |
(10) |
|
|
|
677 |
(4) |
|
|
|
681 |
(6) |
|
|
|
687 |
(12) |
|
|
|
699 |
(6) |
|
|
|
705 |
(10) |
|
|
|
715 |
(6) |
|
|
|
721 |
(8) |
|
|
|
729 |
(4) |
|
|
|
733 |
(4) |
|
|
|
737 |
(4) |
|
|
|
741 |
(6) |
|
|
|
747 |
(4) |
|
|
|
751 |
(4) |
|
|
|
755 |
(4) |
|
|
|
759 |
(6) |
|
|
|
765 |
(6) |
|
|
|
771 |
(6) |
|
|
|
777 |
(4) |
|
|
|
781 |
(6) |
|
|
|
787 |
(6) |
|
|
|
793 |
(6) |
|
|
|
799 |
(4) |
|
|
|
803 |
(6) |
|
|
|
809 |
(4) |
|
|
|
813 |
(4) |
|
|
|
817 |
(8) |
|
|
|
825 |
(4) |
|
|
|
829 |
(8) |
|
|
|
837 |
(4) |
|
|
|
841 |
(6) |
|
|
|
847 |
(6) |
|
|
|
853 |
(6) |
|
|
|
859 |
(4) |
|
|
|
863 |
(8) |
|
|
|
871 |
(4) |
|
|
|
875 |
(4) |
|
|
|
879 |
(4) |
|
|
|
883 |
(6) |
|
|
|
889 |
(6) |
|
Index by Drug Name |
|
895 |
(16) |
|
Index by Use |
|
911 |
(8) |
|
Index by Class |
|
919 |
(4) |
|
Abbreviations |
|
923 |
|
Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California, San Diego, Clinical Professor of Psychiatry and Neuroscience at the University of California, Riverside, and Honorary Visiting Senior Fellow in Psychiatry at the University of Cambridge.
Lisainfo e-raamatute kohta